Observational study / 2011
Higher serum methylglyoxal derivatives were linked to faster cognitive decline over time in elderly individuals.
Researchers evaluated the relationship between baseline serum methylglyoxal derivatives (sMG) and cognitive decline using Tobit mixed regression models in 267 non-demented elderly subjects. In the fully adjusted model, each unit increase in baseline sMG was associated with an annual decline of 0.26 MMSE points (p = 0.03). This relationship remained significant with additional risk factors and showed no significant interactions with diabetes, sex, age, kidney function, or ApoE4 genotype.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 267 non-demented elderly individuals
- What was measured
- Cognitive decline measured by the Mini Mental State Exam (MMSE) over time
THE PAPER
Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals.
Beeri MS, Moshier E, Schmeidler J, Godbold J, Uribarri J, Reddy S, Sano M, Grossman HT, Cai W, Vlassara H, Silverman JM. Mech Ageing Dev, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.